Early Access — free while we kick the tires
EdgarHawk

MATLIN DAVID J

Director

Director
2 filings analyzed · 1 company · Latest 2026-01-13

Companies

Company Buys Sells Direction
Clene Inc. CLNN 2 0 Net buying

Activity

January 2026
2026-01-13 Clene Inc. CLNN
high
Buy
33,333 shares
$216,664
Significance 7/10

Director Matlin buys 33,333 shares at $6.50 in CLNN; stock now -59.2% from 52-week high, down -24.7% in 30 days.

Director David J. Matlin purchased 33,333 shares at $6.50 on 2026-01-13, increasing his holdings from 444,491 to 477,824 shares (+7.5%). The purchase occurs as CLNN trades at $5.10, significantly below the transaction price and down -59.2% from its 52-week high of $12.50, with the stock declining -24.7% over the prior 30 days and -42.6% over 90 days. Across his prior two purchases at CLNN specifically, Matlin demonstrated strong timing at the 90-day mark (returning +5.0% and +1937.6% respectively), establishing a pattern of well-timed accumulation at this ticker. However, the company's fundamentals are severely deteriorated: revenue collapsed -47.7% year-over-year, the latest quarter shows just $15.0K in revenue with a net loss of $-8.8M, and the company remains unprofitable. The purchase against this backdrop—after substantial recent price declines—presents a test of whether Matlin's historical timing acumen extends into a sharply weakened operational environment.

October 2024
2024-10-02 Clene Inc. CLNN
high
Buy
92,307 shares
$438,458
Significance 7/10

Director MATLIN DAVID J buys 92,307 shares of CLNN at $4.75; holdings +26.2%; cluster pattern with 2 other insiders buying within 14 days.

Director MATLIN DAVID J purchased 92,307 shares at $4.75, increasing his holdings by 26.2% to 444,491 shares. The transaction occurs within a cluster: 2 other insiders also bought within the past 14 days, suggesting coordinated confidence at this price level. At CLNN specifically, his prior buy on 2023-11-10 returned +1797.6% over 90 days, indicating a track record of well-timed accumulation at this ticker. The current stock trades at $4.89, -55.1% from its 52-week high of $10.90, creating a valuation backdrop that may have motivated this director-level accumulation. The company remains unprofitable (net income $-6.8M in the latest quarter) with minimal quarterly revenue ($91.0K), but shows annual revenue growth of +38.3%, leaving fundamental trajectory uncertain and making insider conviction—expressed through significant share increase—a notable signal for investors to track.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access